DCs demonstrate functional duality: They orchestrate antitumor responses through tumor antigen presentation while concurrently suppressing cytotoxic T cell recruitment and down-regulating costimulatory molecule expression, thereby promoting immunosuppression via IL-10 and TGF-β secretion. The gene discussed is IL10; the disease is neoplasm.